Opinion

Video

Episode 2 Video: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Author(s):

Wayne Kuang, MD,Steven Maislos, MD

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

      Subscribe Now!
      Related Videos
      1 expert is featured in this series.
      Managing Abiraterone Intolerance: Alternative Dosing Strategies in Practice
      1 expert is featured in this series.
      Decision-Making and Multidisciplinary Counseling for Nodal Involvement on PSMA PET
      Rethinking First-Line Treatments: Will BCG Continue to Be the Standard in NMIBC?
      Rethinking First-Line Treatments: Will BCG Continue to Be the Standard in NMIBC?
      In the Pipeline: Novel Treatment Delivery Methods for NMIBC
      In the Pipeline: Novel Treatment Delivery Methods for NMIBC
      Urology Times Mitomycin RX Review Square Thumb
      RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice
      Urology Times Mitomycin RX Review Square Thumb
      RX Review: TURBT vs chemoablation for low-grade, intermediate-risk NMIBC
      Urology Times Mitomycin RX Review Square Thumb
      RX Review: A paradigm shift for low-grade, intermediate-risk NMIBC
      Urology Times Mitomycin RX Review Square Thumb
      RX Review: How mitomycin for intravesical solution works in treating LG-IR-NMIBC
      Urology Times Mitomycin RX Review Square Thumb
      RX Review: Redefining treatment for LG-IR-NMIBC
      2 experts are featured in this series.
      The Logistical Challenges in ccRCC Treatment
      Related Content
      Survey: New NMIBC treatments face slow uptake
      June 2nd 2025

      Survey: New NMIBC treatments face slow uptake

      Benjamin P. Saylor
      Results of an exclusive Urology Times survey point to urologists preferring intravesical chemotherapy for treating BCG-unresponsive NMIBC.
      Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD
      June 30th 2025

      Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

      Amy M. Pearlman, MD
      Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.
      Du Geon Moon, MD, PhD | Credit: Korea University College of Medicine
      April 27th 2025

      Sildenafil/Clomipramine Combo Boosts Outcomes in Premature Ejaculation

      Patrick Campbell
      A phase 3 trial reveals a combination therapy for premature ejaculation significantly enhances treatment outcomes.
      Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD
      June 19th 2025

      Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD

      Amy M. Pearlman, MD
      The conversation covers practical, case-based strategies for counseling MSM patients.
      Nathan Lawrentschuk, MBBS, PhD | Credit: Epworth Healthcare
      April 26th 2025

      ADAM, a long-term, injectable male birth control, shows promise at AUA 2025

      Patrick Campbell
      A groundbreaking male contraceptive shows promising safety results, offering a reversible option for couples seeking effective birth control.
      Stacy Loeb, MD, MSc, PhD | Credit: NYU Langone Health
      April 26th 2025

      TikTok, social media does more harm than good for prostate cancer education

      Patrick Campbell
      Social media spreads significant misinformation about prostate cancer. Experts urge clinicians to provide trusted information sources.
      © 2025 MJH Life Sciences

      All rights reserved.